JUN 22, 2020 9:20 AM PDT

Methylation Markers That Can be Used to Diagnose Pancreatic Cancer

WRITTEN BY: Jasper Cantrell

Diagnostic tests are the unsung heroes of cancer treatment. While there are more treatments for cancer coming out every year, prevention and early treatment remains the best option by far. The development of modern diagnostic tools usually centers around protein or genetic markers.

Epigenetics has become one of the leading paths for diagnostics. Epigenetics is essentially the study of how genes are regulated indirectly. DNA methylation is an example of this. DNA methylation suppresses the expression of the DNA that is being methylated. In cancer, there are several sites in the genome that are abnormally methylated. These could, in theory, be used as markers for cancer diagnostics. A team from Nagoya University in Japan hypothesized that they could use DNA methylation markers to create a method that could diagnose pancreatic cancer patients.

First, they needed to identify the DNA methylation markers in question. They began by identifying all highly methylated DNA sites in pancreatic cancer samples. Then they narrowed down the possibilities by logical reasoning, bringing the possible markers down to five from 5,575 initial hits.  

Using The Cancer Genome Database (TCGA) as well as their own testing, the team set out to validate these markers for the diagnosis of pancreatic cancer. At least one of the five methylation markers were found in nearly all pancreatic cancers tested. In healthy tissues, none of the sites were methylated. The team also found that including the commonly mutated KRAS as a marker alongside the five DNA methylation markers, the accuracy of the test could reach 98% correct.

To implement these markers as a diagnostic tool, the team established an MBP-ddPCR method. The method needed something called cell-free DNA (cfDNA), which is found in blood or serum. Unfortunately, cfDNA is not very enriched in either. To get around this, they first collected methylated DNA using a methylation binding protein (MBP), then amplified it to see if the methylation marker sites were present. This method managed to produce reliable data on a tenth of the cfDNA.

Using this method, the team tested forty-seven pancreatic cancer patients alongside a control group of healthy volunteers. Alone, the five methylation markers could not reach a statistically significant accuracy. However, alongside KRAS mutation markers, it was nearly 70 percent accurate at diagnosing pancreatic cancer.

While not perfect, most diagnostic tools today are not the most accurate. The issue of accuracy is often overcome by conducting three or more tests and examining all three. This method also showed the ability to identify pancreatic cancer in earlier stages, before malignancy commonly sets in. Overall, this novel test shows promise for future studies beyond just pancreatic cancer. The group concludes, “Although further optimization may be required for practical clinical use, the combination of DNA methylation markers with highly sensitive MBD–ddPCR may provide a non-invasive effective diagnostic strategy for identifying devastating pancreatic cancers.”

Sources: PLOS One, Garvin Institute of Medical Research
 

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
JUN 23, 2020
Cancer
Why are certain people more vulnerable to carcinogens?
JUN 23, 2020
Why are certain people more vulnerable to carcinogens?
A study from the University of Hawaii Cancer Center entitled, "Tumour predisposition and cancer syndromes as models ...
JUN 28, 2020
Cell & Molecular Biology
Insight Into How Dietary Changes Could Affect Cancer Therapies
JUN 28, 2020
Insight Into How Dietary Changes Could Affect Cancer Therapies
Researchers are investigating the complex relationship between cancer, diet, and metabolism in cells, and are attempting ...
JUL 18, 2020
Cancer
Clinical trials go forth for osteosarcoma in dogs and glioblastoma multiforme in humans using the same precision medicine
JUL 18, 2020
Clinical trials go forth for osteosarcoma in dogs and glioblastoma multiforme in humans using the same precision medicine
A development in precision medicine in cancer treatment for dogs has led to a similar advancement in cancer treatment fo ...
JUL 30, 2020
Cardiology
Protecting the Heart Against Cardiotoxicity
JUL 30, 2020
Protecting the Heart Against Cardiotoxicity
Doxorubicin is a potent chemotherapy drug used for many different cancers. Unfortunately, like all chemotherapies, doxor ...
AUG 06, 2020
Clinical & Molecular DX
Gut Feeling: Spotting the Early Signs of Gastric Cancer
AUG 06, 2020
Gut Feeling: Spotting the Early Signs of Gastric Cancer
In a study published in Science Advances, scientists propose a new method for diagnosing gastric cancer, the third leadi ...
AUG 09, 2020
Cancer
Reducing post-surgery metastasis in colorectal cancer patients
AUG 09, 2020
Reducing post-surgery metastasis in colorectal cancer patients
Scientists have recently shown the successful reduction of metastasis in post-surgery colorectal cancer patients. The st ...
Loading Comments...